SI1446119T1 - Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada - Google Patents

Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada

Info

Publication number
SI1446119T1
SI1446119T1 SI200230311T SI200230311T SI1446119T1 SI 1446119 T1 SI1446119 T1 SI 1446119T1 SI 200230311 T SI200230311 T SI 200230311T SI 200230311 T SI200230311 T SI 200230311T SI 1446119 T1 SI1446119 T1 SI 1446119T1
Authority
SI
Slovenia
Prior art keywords
compositions
common cold
xylometazoline
ipatropium
treatment
Prior art date
Application number
SI200230311T
Other languages
English (en)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of SI1446119T1 publication Critical patent/SI1446119T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
SI200230311T 2001-09-18 2002-09-18 Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada SI1446119T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
EP02765268A EP1446119B1 (en) 2001-09-18 2002-09-18 Compositions comprising ipatropium and xylometazoline for treatment of the common cold
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (1)

Publication Number Publication Date
SI1446119T1 true SI1446119T1 (sl) 2006-08-31

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230311T SI1446119T1 (sl) 2001-09-18 2002-09-18 Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada

Country Status (21)

Country Link
US (2) US7652030B2 (sl)
EP (2) EP1661570A3 (sl)
JP (1) JP4500045B2 (sl)
KR (1) KR100810872B1 (sl)
CN (1) CN1290502C (sl)
AT (1) ATE318601T1 (sl)
BR (1) BRPI0212586B8 (sl)
CA (1) CA2460140C (sl)
DE (1) DE60209511T2 (sl)
DK (1) DK1446119T3 (sl)
EA (1) EA008165B1 (sl)
ES (1) ES2259098T3 (sl)
HK (1) HK1067984A1 (sl)
HU (1) HU226527B1 (sl)
MX (1) MXPA04002500A (sl)
NO (1) NO334441B1 (sl)
NZ (1) NZ531792A (sl)
PL (1) PL208686B1 (sl)
PT (1) PT1446119E (sl)
SI (1) SI1446119T1 (sl)
WO (1) WO2003024433A2 (sl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
KR100810872B1 (ko) * 2001-09-18 2008-03-06 니코메드 덴마크 에이피에스 감기 치료용 조성물
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1713472A2 (en) * 2004-02-06 2006-10-25 MEDA Pharma GmbH & Co. KG Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
BRPI0518396A2 (pt) * 2004-12-27 2008-11-18 Eisai R&D Man Co Ltd mÉtodo para estabilizaÇço de droga anti-demÊncia
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
MX2016014399A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizador.
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
EA032719B1 (ru) * 2014-12-24 2019-07-31 Ярдан-Галенски Лабораторий Д.Д. Назальная лекарственная форма против заложенности носа
MX2015016549A (es) 2015-12-02 2017-06-01 Cortés Borrego Pablo Combinacion de oximetazolina e ipratropio en aplicacion topica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183640T1 (de) 1991-11-19 1999-09-15 Univ Virginia Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
AU6878098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Topical nasal antiinflammatory compositions
EP1051155B1 (en) * 1998-01-30 2002-06-26 Novartis Consumer Health S.A. Nasal solutions
WO1999065464A1 (en) 1998-06-18 1999-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
IL147023A0 (en) 1999-06-22 2002-08-14 Boehringer Ingelheim Int Stable xylometazoline and oxymetazoline solution
KR100810872B1 (ko) * 2001-09-18 2008-03-06 니코메드 덴마크 에이피에스 감기 치료용 조성물

Also Published As

Publication number Publication date
DE60209511D1 (de) 2006-04-27
JP2005505569A (ja) 2005-02-24
PL370536A1 (en) 2005-05-30
KR100810872B1 (ko) 2008-03-06
KR20040049849A (ko) 2004-06-12
EP1446119B1 (en) 2006-03-01
US20100093783A1 (en) 2010-04-15
CN1290502C (zh) 2006-12-20
HK1067984A1 (en) 2005-04-22
US8450339B2 (en) 2013-05-28
WO2003024433A2 (en) 2003-03-27
PT1446119E (pt) 2006-07-31
MXPA04002500A (es) 2004-11-22
CA2460140A1 (en) 2003-03-27
US20040248924A1 (en) 2004-12-09
HUP0402075A2 (hu) 2005-02-28
ATE318601T1 (de) 2006-03-15
EA008165B1 (ru) 2007-04-27
NZ531792A (en) 2006-02-24
NO20041070L (no) 2004-05-18
BRPI0212586B8 (pt) 2021-05-25
ES2259098T3 (es) 2006-09-16
EA200400444A1 (ru) 2005-02-24
PL208686B1 (pl) 2011-05-31
US7652030B2 (en) 2010-01-26
EP1446119A2 (en) 2004-08-18
JP4500045B2 (ja) 2010-07-14
HUP0402075A3 (en) 2008-04-28
DK1446119T3 (da) 2006-07-10
CN1555263A (zh) 2004-12-15
EP1661570A3 (en) 2012-10-24
HU226527B1 (hu) 2009-03-30
DE60209511T2 (de) 2006-10-05
BR0212586B1 (pt) 2013-11-19
CA2460140C (en) 2009-09-01
WO2003024433A3 (en) 2004-06-10
NO334441B1 (no) 2014-03-03
BR0212586A (pt) 2004-10-13
EP1661570A2 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
HK1067984A1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
BR9812361A (pt) Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
HK1057330A1 (en) Use of hydroxyethylrutosides for treating symptomsof common cold, allergic rhinitis and infections relating to the respiratory tract
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2001066564A3 (en) Gamma-secretase inhibitors
TW200504078A (en) Therapeutically active compounds and their use
SG152257A1 (en) Topical preparation containing ambroxol
NO952310L (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av Parkinsons sykdom og Parkinsonianske syndromer
MXPA03010761A (es) Combinaciones farmaceuticas.
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
DE60322417D1 (en) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
WO2002072584A3 (en) Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
MXPA03011466A (es) Macrociclos utiles en tratamiento de enfermedades de alzheimer.
WO2004082706A3 (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
WO2002072571A3 (en) Pyridinyl pyrazoles useful for the treatment of copd
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
BR0212329A (pt) Métodos para tratar doença pulmonar
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2005039483A3 (en) Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity